Anionic clays for sunscreen agent safe use: Photoprotection, photostability and prevention of their skin penetration

被引:91
作者
Perioli, L
Ambrogi, V
Bertini, B
Ricci, M
Nocchetti, M
Latterini, L
Rossi, C
机构
[1] Univ Perugia, Dipartimento Chim & Tecnol Farmaco, I-06123 Perugia, Italy
[2] Univ Perugia, Dipartimento Chim, I-06100 Perugia, Italy
关键词
sunscreen agent; para-aminobenzoic acid; hydrotalcite; intercalation; photoprotection; photostability;
D O I
10.1016/j.ejpb.2005.08.001
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The use of sunscreen preparations is recently growing and their efficacy and safety must be taken into account since they are applied on the skin frequently and for many hours. Exposition to sunlight, in fact, can cause sunscreen photodegradation and determine their decrease in UV protection often with the occurrence of allergic and/or toxic degradation products. A high photostability is hence very important for their effectiveness and safety. The aim of this work is to obtain new sunscreen formulations stabilized by intercalating PABA, within the lamellar structures of two kinds of hydrotalcite. PABA was chosen as model sunscreen because of its high photoinstability and photosensitizing properties that nowadays bar its utilization. Both intercalated products showed an increased protection range and, in one case, an improved sunscreen photostability. Sunscreen release from creams containing intercalated or free PABA was evaluated as well. The very low or negligible sunscreen release, obtained from the intercalated product loaded formulations, resulted in a lack of a close contact between skin and filter with the consequence that cutaneous reactions and allergy problems are eliminated. The use of these materials resulted in a good strategic technological approach in order to increase efficacy and safety of solar products. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:185 / 193
页数:9
相关论文
共 39 条
[1]
AMBROGI V, 2002, AAPS PHARMSCITECH, V3, P1
[2]
AMBROSIO M, 1992, COSMESI DERMATOLOGIC, V41, P7
[3]
Berset G, 1996, Int J Cosmet Sci, V18, P167, DOI 10.1111/j.1467-2494.1996.tb00145.x
[4]
BISH DL, 1980, B MINERAL, V103, P170
[5]
Broadbent JK, 1996, J CHROMATOGR A, V732, P101
[6]
Cantrell T., 2002, PHARMACEUTICS, V425, P1
[7]
Carr SW, 1995, Patent No. [5474762, US5474762]
[8]
HYDROTALCITE-TYPE ANIONIC CLAYS: PREPARATION, PROPERTIES AND APPLICATIONS [J].
Cavani, F. ;
Trifiro, F. ;
Vaccari, A. .
CATALYSIS TODAY, 1991, 11 (02) :173-301
[9]
CHODOROWSKI FX, 2001, Patent No. 2001024768
[10]
RELEASE OF CORTICOIDS FROM OLEAGINOUS OINTMENT BASES CONTAINING DRUG IN SUSPENSION [J].
CHOWHAN, ZT ;
PRITCHARD, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (05) :754-759